|

Asthma Clinical Trials in Oklahoma

19 recruiting studies across 2 cities

Browse by City

Oklahoma City
18 trials
Tulsa
3 trials

All Trials in Oklahoma

Phase
Trial Phase Dist.
A Study to Compare the Efficacy, Safety and Tolerability of FF/UMEC/VI With FF/VI in 12-17-year-olds With AsthmaPhase 3<1 mi
A Study to Learn About the Study Medicine Called PF-07275315 in People With Moderate-To-Severe AsthmaPhase 2<1 mi
Spirometric Response to Bronchial Thermoplasty in Patients With Severe Asthma—<1 mi
A Study to Test if a Fixed-Dose Combination of Fluticasone Propionate/Albuterol Sulfate is Effective in Preventing Asthma ExacerbationsPhase 3<1 mi
Evaluating the Efficacy and Safety of PT027 Compared With PT007 Administered As Needed in Participants 12 to < 18 Years of Age With AsthmaPhase 3<1 mi
Randomised Clinical Trial to Investigate Efficacy and Safety of Benralizumab 30 mg SC as an add-on Therapy in Uncontrolled Eosinophilic Asthma Patients Treated With Medium-dose ICS-LABA Compared to Conventional Escalation to High-dose ICS-LABA TreatmentPhase 3<1 mi
A Study to Investigate the Efficacy and Safety of Tezepelumab Compared With Placebo in Children 5 to < 12 Years Old With Severe AsthmaPhase 3<1 mi
Pharmacokinetics, Pharmacodynamics, and Safety Profile of Understudied Drugs Administered to Children Per Standard of Care (POPS)—<1 mi
Timely Administration of IV Magnesium Sulfate in Patients With a Moderate Asthma ExacerbationEarly 1<1 mi
A Phase 1, Randomized, Double-blind, Placebo-controlled Study Evaluating AMG 691 in Healthy Participants and Participants With Mild-to-Moderate AsthmaPhase 1<1 mi
Efficacy of Dupilumab Added to Medium Dose Inhaled Corticosteroid/Long-acting Beta-agonist (ICS/LABA) in Comparison to ICS Dose Escalation to High Dose ICS/LABA in Adolescent and Adult Patients With Uncontrolled AsthmaPhase 4<1 mi
A Randomized, Double-Blind, Placebo-Controlled Trial on Efficacy and Safety of Fluticasone Propionate/Albuterol Sulfate Combination in Participants 12 Years and Older With AsthmaPhase 3<1 mi
A Study of KT-621 Administered Orally to Adult Participants With Moderate to Severe Eosinophilic AsthmaPhase 213 mi
Study of Lunsekimig (SAR443765) Compared With Placebo in Adults With High-risk AsthmaPhase 213 mi
Long-term Safety and Efficacy Evaluation of Lunsekimig (SAR443765) in Adult Participants With Asthma.Phase 213 mi
Study to Evaluate the Safety, Pharmacology and Efficacy of WIN378 in Adults With Moderate or Severe AsthmaPhase 213 mi
Dose Range Finding Study to Assess Efficacy and Safety of Tozorakimab in Adults With Uncontrolled Asthma on Medium-to-High Dose Inhaled CorticosteroidsPhase 213 mi
A Long-Term Safety and Efficacy Study of Verekitug (UPB-101) in Adult Participants With Severe Asthma (VALOUR)Phase 213 mi
A Study to Evaluate Solriktug in Adult Participants With AsthmaPhase 213 mi

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.